We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 PR Newswire MINNEAPOLIS, May 8, 2024 MINNEAPOLIS, May 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) PR Newswire MINNEAPOLIS, May 7, 2024 MINNEAPOLIS, May 7, 2024 /PRNewswire/...
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS PR Newswire MINNEAPOLIS, May 1, 2024 MINNEAPOLIS, May 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its...
BIO-TECHNE DECLARES DIVIDEND PR Newswire MINNEAPOLIS, May 1, 2024 MINNEAPOLIS, May 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided...
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS PR Newswire MINNEAPOLIS, April 30, 2024 MINNEAPOLIS, April 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC PR Newswire MINNEAPOLIS, April 29, 2024 MINNEAPOLIS, April 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY PR Newswire MINNEAPOLIS, April 26, 2024 MINNEAPOLIS, April 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS PR Newswire MINNEAPOLIS, April 23, 2024 Bio-Techne enforces intellectual property for gold standard RNAscope® ISH...
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, April 10, 2024 MINNEAPOLIS, April 10, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 6.51 | 9.22880635101 | 70.54 | 77.98 | 70.012 | 1796207 | 75.40586543 | CS |
4 | 7.41 | 10.6404365307 | 69.64 | 77.98 | 61.16 | 1240747 | 68.31581586 | CS |
12 | 8.64 | 12.6297324952 | 68.41 | 78.745 | 61.16 | 1115688 | 70.5084613 | CS |
26 | 17.11 | 28.5452118785 | 59.94 | 78.745 | 55.63 | 1112835 | 69.60745305 | CS |
52 | -6.07 | -7.30269489894 | 83.12 | 89.91 | 51.79 | 1035323 | 71.67016527 | CS |
156 | -28.2325 | -26.8159475696 | 105.2825 | 135.9625 | 51.79 | 631294 | 80.21432577 | CS |
260 | 26.645 | 52.861819264 | 50.405 | 135.9625 | 38.7925 | 447489 | 77.71616957 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions